Ascendent Capital invests over $7m in China's BioChain

Ascendent Capital invests over $7m in China's BioChain

Nguyen Thi Bich Ngoc

11 November, 2016

Ascendent Capital partners biotechnology China Everbright fundraising investment private equite

Printed by Unregistered user on Wed, 10 Dec 2025 11:43:50 GMT

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

Subscribe to Newsletter

Read more from Greater China

Venture Capital

Temasek, HongShan-backed D3 Bio raises $108m in Series B round

Earnings and Results

Chinese sovereign wealth fund CIC’s profit soars 30.4% on investment gains